Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Amyloidosis and Alzheimer’s disease

Ghiso, Jorge, Frangione, Blas · 2002 · Advanced Drug Delivery Reviews

Abstract

Alzheimer's disease (AD) is the most frequent type of amyloidosis in humans and the commonest form of dementia. Extracellular Abeta amyloid deposits in the form of amyloid plaques and cerebral amyloid angiopathy as well as intraneuronal neurofibrillary tangles co-exist in the brain parenchyma of AD patients, the cognitive areas being the most severely affected. This review focuses on the potential role of amyloid in the development of neurodegeneration and presents studies of AD and other unrelated inherited dementia syndromes associated with neuronal loss and amyloid deposition in the brain.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(02)00149-7

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Research works printed but not linked: 64

  1. Dobson, 1999, Protein misfolding, evolution and disease, Trends Biochem. Sci., 24, 329, 10.1016/S0968-0004(99)01445-0 · DOI · Paper page
  2. Ferreira, 2001, Protein dynamics, folding and misfolding: From basic physical chemistry to human conformational diseases, FEBS Lett., 498, 129, 10.1016/S0014-5793(01)02491-7 · DOI
  3. Thomas, 1995, Defective protein folding as a basis of human disease, Trends Biochem. Sci., 20, 456, 10.1016/S0968-0004(00)89100-8 · DOI · Paper page
  4. Martin, 1999, Molecular basis of the neurodegenerative disorders, N. Engl. J. Med., 340, 1970, 10.1056/NEJM199906243402507 · DOI · Paper page
  5. Paulson, 2000, Polyglutamine disease and neuronal cell death, Proc. Natl. Acad. Sci. USA, 97, 12957, 10.1073/pnas.210395797 · DOI
  6. Rajagolapan, 2001, Alpha synuclein aggregation: is it the toxic gain of function responsible for the neurodegeneration in Parkinson’s disease, Mech. Ageing Dev., 122, 1499, 10.1016/S0047-6374(01)00283-4 · DOI
  7. Cohen, 1999, Protein misfolding and Prion diseases, J. Mol. Biol., 293, 313, 10.1006/jmbi.1999.2990 · DOI
  8. Prusiner, 2001, Shattuck lecture: Neurodegenerative diseases and prions, N. Engl. J. Med., 344, 1548, 10.1056/NEJM200105173442006 · DOI · Paper page
  9. Westermark, 1999, Nomenclature of amyloid fibril proteins, Amyloid, 6, 62
  10. Huilgol, 1998, Cytokeratins in primary cutaneous amyloidosis, Australas J. Dermatol., 39, 81, 10.1111/j.1440-0960.1998.tb01253.x · doi:10.1111/j.1440-0960.1998.tb01253.x
  11. Vidal, 1999, A stop-codon mutation in the BRI gene associated with familial British dementia, Nature, 399, 776, 10.1038/21637 · DOI · Paper page
  12. Häggqvist, 1999, Medin: An integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid, Proc. Natl. Acad. Sci. USA, 96, 8669, 10.1073/pnas.96.15.8669 · DOI · Paper page
  13. Schmitt-Bernard, 2000, In vitro creation of amyloid fibrils from native Arg124Cys mutated βGH3(110-131) peptides, and its relevance for lattice corneal amyloid dystrophy type I, Biochem. Biophys. Res. Commun., 273, 649, 10.1006/bbrc.2000.2955 · doi:10.1006/bbrc.2000.2955
  14. Wisniewski, 1997, Biology of Aβ amyloid in Alzheimer’s disease, Neurobiol. Dis., 4, 313, 10.1006/nbdi.1997.0147 · DOI · Paper page
  15. Selkoe, 2001, Alzheimer’s disease: genes, proteins, therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
  16. Goldgaber, 1987, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease, Science, 235, 877, 10.1126/science.3810169 · DOI · Paper page
  17. Robakis, 1987, Molecular cloning and characterization of a cDNA encoding the neuritic plaque amyloid peptides, Proc. Natl. Acad. Sci. USA, 84, 4190, 10.1073/pnas.84.12.4190 · DOI · Paper page
  18. Vigo-Pelfrey, 1993, Characterization of β-amyloid peptide from human cerebrospinal fluid, J. Neurochem., 61, 1965, 10.1111/j.1471-4159.1993.tb09841.x · DOI · Paper page
  19. Ghiso, 1997, Alzheimer’s soluble amyloid β is a normal component of human urine, FEBS Lett., 408, 105, 10.1016/S0014-5793(97)00400-6 · DOI
  20. Tabaton, 1994, Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid, Biochem. Biophys. Res. Commun., 200, 1598, 10.1006/bbrc.1994.1634 · DOI
  21. Nästrand, 1994, Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging, Proc. Natl. Acad. Sci. USA, 91, 8378, 10.1073/pnas.91.18.8378 · DOI · Paper page
  22. Teller, 1996, Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down’s syndrome, Nat. Med., 2, 93, 10.1038/nm0196-93 · DOI · Paper page
  23. Zlokovic, 1996, Gp330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer’s Amyloid β at the blood–brain and blood–cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. USA, 93, 4229, 10.1073/pnas.93.9.4229 · DOI · Paper page
  24. van Duinen, 1987, Hereditary cerebral Hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 84, 5991, 10.1073/pnas.84.16.5991 · DOI · Paper page
  25. Luyendijk, 1964, Intracerebral haematomas. A clinical study of 40 surgical cases, Psychiat. Neurol. Neurochir., 67, 445
  26. Luyendijk, 1988, Hereditary cerebral hemorrhage caused by cortical amyloid angiopathy, J. Neurol. Sci., 85, 267, 10.1016/0022-510X(88)90186-4 · DOI
  27. Haan, 1989, Hereditary cerebral hemorrhage with amyloidosis-Dutch type: clinical characteristics, Clin. Neurol. Neurosurg., 91, 285, 10.1016/0303-8467(89)90003-6 · DOI
  28. Wattendorff, 1982, Familial cerebral amyloid angiopathy presenting as recurrent cerebral hemorrhage, J. Neurol. Sci., 55, 121, 10.1016/0022-510X(82)90094-6 · DOI · Paper page
  29. Levy, 1990, Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
  30. Wisniewski, 1991, Peptides homologous to the amyloid protein of Alzheimer’s disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation, Biochem. Biophys. Res. Commun., 173, 1247, 10.1016/0006-291X(91)91706-I · DOI · Paper page
  31. Miravalle, 2000, Substitutions at codon 22 of Alzheimer’s Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells, J. Biol. Chem., 275, 27110, 10.1016/S0021-9258(19)61486-9 · doi:10.1016/s0021-9258(19)61486-9 · Paper page
  32. Melchor, 2000, Charge alterations of E22 enhance the pathogenic properties of amyloid beta protein, J. Neurochem., 74, 2209, 10.1046/j.1471-4159.2000.0742209.x · DOI
  33. Kamino, 1992, Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region, Am. J. Hum. Genet., 51, 998
  34. Bugiani, 1998, A new AβPP mutation produces hereditary cerebral hemorrhage in an Italian kindred, Neurobiol. Aging, 19, S238
  35. Tagliavini, 1999, A new AβPP mutation related to hereditary cerebral hemorrhage, Alzheimer’s Rep., 2, 23
  36. Hendriks, 1992, Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene, Nat. Genet., 1, 218, 10.1038/ng0692-218 · DOI · Paper page
  37. Eckman, 1997, A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of Aβ42(43), Hum. Mol. Genet., 6, 2087, 10.1093/hmg/6.12.2087 · DOI · Paper page
  38. Murrell, 1991, A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease, Science, 254, 97, 10.1126/science.1925564 · DOI · Paper page
  39. Checler, 1999, Presenilins: Multifunctional proteins involved in Alzheimer’s disease pathology, IUBMB Life, 48, 33, 10.1080/713803480 · DOI
  40. Saunders, 1993, Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases, Lancet, 342, 710, 10.1016/0140-6736(93)91709-U · DOI · Paper page
  41. Mayeux, 1993, The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease, Ann. Neurol., 34, 752, 10.1002/ana.410340527 · DOI · Paper page
  42. Ueki, 1993, A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer’s disease, Neurosci. Lett., 163, 166, 10.1016/0304-3940(93)90373-S · DOI
  43. Mahley, 1999, Apolipoprotein E: from atherosclerosis to Alzheimer’s disease and beyond, Curr. Opin. Lipidol., 10, 207, 10.1097/00041433-199906000-00003 · DOI · Paper page
  44. Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  45. Wisniewski, 1993, Apolipoprotein E: binding to soluble Alzheimer’s beta-amyloid, Biochem. Biophys. Res. Commun., 192, 359, 10.1006/bbrc.1993.1423 · DOI · Paper page
  46. Strittmatter, 1994, Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype, Exp. Neurol., 125, 163, 10.1006/exnr.1994.1019 · DOI · Paper page
  47. Wisniewski, 1994, Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145, 1030
  48. Holtzman, 2000, Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model, Ann. Neurol., 47, 739, 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8
  49. Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer’s cytoskeletal pathology, Proc. Natl. Acad. Sci. USA, 83, 4913, 10.1073/pnas.83.13.4913 · DOI · Paper page
  50. Wood, 1986, Neurofibrillary tangles in Alzheimer’s disease share antigenic determinants with the axonal microtubule-associated protein tau, Proc. Natl. Acad. Sci. USA, 83, 4040, 10.1073/pnas.83.11.4040 · DOI · Paper page
  51. Kosik, 1986, Microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 83, 4044, 10.1073/pnas.83.11.4044 · DOI · Paper page
  52. Ghiso, 2001, Chromosome 13 dementia syndromes as models of neurodegeneration, Amyloid J. Prot. Fold. Dis., 8, 277, 10.3109/13506120108993826 · DOI
  53. Holton, 2001, Regional distribution of fibrillar and non-fibrillar ABri deposition and its association with neurofibrillary degeneration in Familial British Dementia, Am. J. Pathol., 158, 515, 10.1016/S0002-9440(10)63993-4 · DOI · Paper page
  54. Holton, 2002, Familial Danish dementia: A novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta, J. Neuropath. Exper. Neurol., 61, 254, 10.1093/jnen/61.3.254 · DOI
  55. Ghiso, 2001, Systemic amyloid deposits in familial British dementia, J. Biol. Chem., 276, 43909, 10.1074/jbc.M105956200 · DOI
  56. Joachim, 1989, Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease, Nature, 341, 226, 10.1038/341226a0 · DOI · Paper page
  57. Skodras, 1993, Immunohistochemical localization of amyloid beta-protein deposits in extracerebral tissues of patients with Alzheimer’s disease, Ann. Clin. Lab. Sci., 23, 275
  58. Wen, 1994, Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer’s disease (AD), Down’s syndrome and non-AD normal persons, Acta Neuropathol., 88, 201, 10.1007/BF00293394 · DOI
  59. Gudmundsson, 1972, Hereditary cerebral hemorrhage with amyloidosis, Brain, 95, 387, 10.1093/brain/95.2.387 · DOI · Paper page
  60. Benedikz, 1990, Skin deposits in hereditary cystatin C amyloidosis, Virchows Arch. A, 417, 325, 10.1007/BF01605784 · doi:10.1007/bf01605784
  61. Ghiso, 1986, Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of γ-trace basic protein (cystatin-C), Proc. Natl. Acad. Sci. USA, 83, 2974, 10.1073/pnas.83.9.2974 · DOI · Paper page
  62. Levy, 1989, Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin-C gene, an inhibitor of cysteine proteases, J. Exp. Med., 169, 1771, 10.1084/jem.169.5.1771 · DOI · Paper page
  63. Crawford, 2000, A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease, Neurology, 55, 763, 10.1212/WNL.55.6.763 · DOI
  64. Finckh, 2000, Genetic association of a cystatin C gene polymorphism with late onset Alzheimer’s disease, Arch. Neurol., 57, 1579, 10.1001/archneur.57.11.1579 · DOI

Cited by

See all 158

Metadata

Authors
Ghiso, J., & Frangione, B.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2002-12
Volume
54
Issue
12
Pages
1539-1551
ISSN
0169-409X
Cited by
158
References
18
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloidosis and Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/s0169-409x(02)00149-7
The paper
Ghiso, J., & Frangione, B. (2002). Amyloidosis and Alzheimer’s disease. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(02)00149-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.